Globe says new coverage rates Nemaska "outperform"


https://www.stockwatch.com/News/Item.aspx?bid=Z-C%3aNMX-2626409&symbol=NMX&region=C

2018-06-25 08:04 ET - In the NewsThe Globe and Mail reports in its Saturday, June 23, edition that BMO Nesbitt Burns analyst Joel Jackson began coverage of Nemaska Lithium (92 cents) with an "outperform" rating. The Globe's David Leeder writes in the Eye On Equities column that Mr. Jackson targets the shares at $1.50. Analysts on average target the shares at $2. Mr. Jackson says in a note: "Despite concerns over mid-term lithium prices, the risk/reward on lithium developer Nemaska is compelling considering prospects for NMX's innovative conversion process. Nemaska's potential position at the low end of the lithium hydroxide cost curve could provide insulation from industry pressures if NMX delivers on expected hydroxide costs at US$3k/t versus incumbents at US$5-8k/t. This could result in $3 upside." The Globe's Ian McGugan was upbeat on the outlook for lithium and Nemaska on Dec. 12, 2017. The shares could then be had for $2.24.